Key points
- Amphetamine and methamphetamine are on the federal DOT urine panel; methylphenidate is not a listed analyte (49 CFR 40.85).
- Under 49 CFR 40.137 the employee must prove a legitimate medical explanation, and if the MRO accepts it the result must be verified as negative.
- N.J.S.A. 24:6I-52 protects lawful cannabis use and limits action based on cannabis metabolites alone; it says nothing that restricts amphetamine testing.
- The NJ Attorney General's Law Enforcement Drug Testing Policy screens for amphetamines and uses a sealed medication form reviewed by an MRO.
- As of October 2026, final standards for New Jersey's Workplace Impairment Recognition Expert certification could not be confirmed.
Some ADHD stimulants are the very compound a standard drug test looks for. A positive laboratory result in that case is accurate. What protects a person taking prescribed medication is the review step after the lab, where a prescription can be checked. This page explains how that works in New Jersey as of October 2026, and why New Jersey's well-known cannabis protections do not cover stimulant results. It is general information, not legal advice. Questions about a specific test belong with the program's medical review officer, the agency that regulates your job, or an employment attorney.
What a standard panel looks for
The federal Department of Transportation (DOT) panel in 49 CFR 40.85 is the model many employers follow. Its urine analytes include marijuana metabolite, cocaine metabolite, amphetamine and methamphetamine, opioids and PCP, with an initial screen followed by a confirmatory test.
| Medication type (examples) | On the federal DOT panel? | What to expect |
|---|---|---|
| Amphetamine-based stimulants (mixed amphetamine salts, lisdexamfetamine, dextroamphetamine) | Yes. Amphetamine is a listed analyte. | A true positive for amphetamine. The lab result alone does not show whether use was prescribed. |
| Methylphenidate-based stimulants | No. Methylphenidate is not a listed analyte. | Not tested for on the federal panel. Employers may use broader panels, so ask which one applies. |
| Nonstimulants (atomoxetine, viloxazine, guanfacine) | No | Not on the federal panel. |
Whether methylphenidate can cross-react on an initial amphetamine screen was not settled by the sources reviewed for this guide, so no claim is made either way. Any positive screen should be confirmed by a more specific laboratory method before anyone acts on it.
The medical review officer step on DOT tests
A medical review officer (MRO) reviews confirmed laboratory results before they reach the employer. For DOT-covered testing, 49 CFR 40.137 sets the process:
- The burden is yours. "The employee has the burden of proof that a legitimate medical explanation exists," and you present it at the verification interview. The MRO has discretion to allow up to five more days if there is a reasonable basis to believe you can produce the information.
- A valid prescription can be that explanation.
- An accepted explanation means a negative report. If the MRO finds a legitimate medical explanation, the MRO "must verify the test result as negative."
Keep your pharmacy label or a printout of your fills easy to reach, and return the MRO's call promptly. Commercial drivers, pilots and some other safety-sensitive workers face separate medical standards on top of the drug test. Those are covered in ADHD rules for pilots, commercial drivers and military service.
New Jersey's cannabis law does not cover stimulants
New Jersey's adult-use cannabis law (CREAMMA) includes an employment section, N.J.S.A. 24:6I-52. It bars adverse action against a person because they do or do not use cannabis items, and bars action based solely on cannabinoid metabolites from lawful use. Employers may still test, including on reasonable suspicion, after a workplace accident, and through random, pre-employment or regular screening.
The statute calls for a Workplace Impairment Recognition Expert (WIRE) certification. The Cannabis Regulatory Commission's 2022 guidance describes itself as interim guidance "until the NJ-CRC formulates and approves standards for WIRE certifications," and says a test showing cannabinoid metabolites "alone is insufficient to support an adverse employment action." This guide could not confirm that final WIRE standards had been adopted as of October 2026.
All of that is about cannabis. Nothing in N.J.S.A. 24:6I-52 or the commission's guidance limits testing for amphetamines. A person taking a prescribed stimulant is protected by the verification process and by disability law, not by the cannabis statute. If you also use cannabis, see ADHD medication and cannabis in New Jersey, including why DOT testing treats cannabis differently.
Police and other law enforcement jobs in New Jersey
New Jersey law enforcement agencies under the Attorney General's authority follow the Attorney General's Law Enforcement Drug Testing Policy (revised February 2023). Points that matter for someone on ADHD medication:
- Applicants and trainees are tested, and agencies must run random testing of sworn officers under AG Directive 2018-2.
- The laboratory screen covers amphetamines, among other substances.
- Trainees and officers complete a Drug Testing Medication Information form listing prescription and over-the-counter medications and supplements taken in the past 14 days, sealed in an envelope with the specimen.
- At the applicant stage, the policy says agencies should not use that form, to avoid medical inquiries under the ADA, unless a positive result requires an explanation. The form is used once a conditional offer of employment has been made.
- When a specimen tests positive at both stages, a medical review officer at the State Medical Examiner Toxicology Laboratory reviews the result with the medication form to decide whether a listed medication explains it.
The policy does not tell you how a stimulant prescription is weighed for fitness for duty. Ask the hiring agency directly.
DOT-regulated jobs compared with other employers
Outside cannabis and federally regulated jobs, this guide did not find a New Jersey statute that sets a general drug-testing procedure for private employers. In practice, the employer's written policy, any union contract and the testing vendor's process decide whether an MRO looks at your prescription before the employer sees a result. Ask for the policy in writing.
| DOT-regulated testing | Other private employers in New Jersey | |
|---|---|---|
| Procedure | 49 CFR Part 40, including MRO review | Not bound by Part 40. Many use an MRO by choice. |
| Cannabis results | An MRO may not verify a marijuana result as negative based on a physician's recommendation under a state medical cannabis law (49 CFR 40.151(e)) | CREAMMA limits action based on cannabis metabolites alone |
| Amphetamine results | A valid prescription can lead to a negative report | Depends on the employer's process. Ask whether an MRO reviews results. |
| Questions about prescriptions | Handled in the MRO interview | EEOC guidance: before an offer, employers generally may not ask about lawful prescription drug use. After a positive result, they may ask what medications could explain it. |
The EEOC also says a test for illegal drugs is not a medical examination under the ADA. Whether and how to tell an employer about ADHD more generally is a separate choice, discussed in telling your employer about ADHD in New Jersey.
Before a scheduled test
- Make sure your prescription is current and that a pharmacy label or fill printout is easy to reach.
- Take medication only as prescribed and keep it in the pharmacy container with your name on it.
- Ask which panel will be used and whether an MRO reviews positive results.
- If an MRO calls, call back quickly and ask what documents are needed and by when.
- If you think a result is wrong, ask about confirmation testing and how to challenge it.
If a properly explained result still leads to a job action, see filing a disability discrimination complaint in New Jersey. For the medication itself, adult ADHD treatment describes how medication management works with Dr. Shershow, a psychiatrist focused on adult ADHD who is licensed in New York and New Jersey.
Questions
Will my prescribed Adderall show up on a drug test in New Jersey?
It is expected to. Amphetamine is on the standard federal panel, so the laboratory finding is a true positive. The prescription matters at the review stage, where a medical review officer can report the result as negative.
Does New Jersey's cannabis law protect me if I test positive for a stimulant?
No. N.J.S.A. 24:6I-52 and the Cannabis Regulatory Commission's guidance deal with cannabis only. Protection for a prescribed stimulant comes from MRO review and disability law.
Do I have to list my ADHD medication before a job offer?
EEOC guidance says employers generally may not ask about lawful prescription drug use before an offer. After a positive test, the employer or its MRO may ask what medications could explain the result.
I am applying to a New Jersey police department. How is my prescription handled?
Under the Attorney General's policy, the medication form is generally not used at the applicant stage unless a positive result needs explaining, and it is used once a conditional offer is made. A medical review officer reviews positive results against the form.
Does methylphenidate cause a positive amphetamine screen?
Methylphenidate is not on the federal panel, and the sources reviewed for this guide did not settle whether it can cross-react on an initial screen. A positive screen should be confirmed by a more specific test before any decision.
Sources
- Cornell Legal Information Institute: 49 CFR 40.85, drug testing analytes and cutoff concentrations
- Cornell Legal Information Institute: 49 CFR 40.137, MRO verification of positive results
- Cornell Legal Information Institute: 49 CFR 40.151, what MROs are prohibited from doing
- EEOC: Enforcement Guidance on Preemployment Disability-Related Questions and Medical Examinations (October 10, 1995)
- FindLaw: N.J.S.A. 24:6I-52, cannabis and employment under CREAMMA (current as of January 1, 2024)
- NJ Cannabis Regulatory Commission: Guidance on Workplace Impairment (September 2022)
- NJ Cannabis Regulatory Commission: Workplace and DUI laws
- NJ Office of the Attorney General: Law Enforcement Drug Testing Policy (revised February 2023)
